163 related articles for article (PubMed ID: 33538017)
41. Iris hemangioma of the newborn: Regression after topical timolol.
Izquierdo-Serra J; Dotti-Boada M; Carreras AC; Sanchez-Tinajero CV; Roca MF; Ballús MM
J Fr Ophtalmol; 2020 Feb; 43(2):e69-e71. PubMed ID: 31870668
[No Abstract] [Full Text] [Related]
42. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.
Frommelt P; Juern A; Siegel D; Holland K; Seefeldt M; Yu J; Uhing M; Wade K; Drolet B
Pediatr Dermatol; 2016 Jul; 33(4):405-14. PubMed ID: 27246751
[TBL] [Abstract][Full Text] [Related]
43. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.
Semkova K; Kazandjieva J
Clin Exp Dermatol; 2013 Mar; 38(2):143-6. PubMed ID: 22731954
[TBL] [Abstract][Full Text] [Related]
44. Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma.
Sacchelli L; Vincenzi C; La Placa M; Piraccini BM; Neri I
Contact Dermatitis; 2019 Apr; 80(4):255-256. PubMed ID: 30485454
[No Abstract] [Full Text] [Related]
45. Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohórquez V; Casas M; Caracuel F; Cameán M; Fernández-Anguita MJ; Ramírez-Soto G; Lucero MJ
Pharm Dev Technol; 2015; 20(5):562-9. PubMed ID: 25047057
[TBL] [Abstract][Full Text] [Related]
46. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
Sorrell J; Chamlin SL
Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of Topical Timolol versus Saline in Chronic Venous Ulcers: A Randomized Controlled Trial.
Rai AK; Janani K; Rai R
J Cutan Aesthet Surg; 2020; 13(1):18-23. PubMed ID: 32655246
[TBL] [Abstract][Full Text] [Related]
48. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
49. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
50. Clinical pearl: topical timolol for refractory hypergranulation.
Waldman RA; Lin G; Sloan B
Cutis; 2019 Aug; 104(2):118-119. PubMed ID: 31603955
[TBL] [Abstract][Full Text] [Related]
51. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
52. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".
McMahon P; Oza V; Frieden IJ
Pediatr Dermatol; 2012; 29(1):127-30. PubMed ID: 22256996
[No Abstract] [Full Text] [Related]
53. Topical beta-blockers in dermatologic therapy.
Filoni A; Ambrogio F; De Marco A; Pacifico A; Bonamonte D
Dermatol Ther; 2021 Jul; 34(4):e15016. PubMed ID: 34075667
[TBL] [Abstract][Full Text] [Related]
54. Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea.
Park KH; Jang YH; Chung HY; Lee WJ; Kim DW; Lee SJ
J Dermatolog Treat; 2015; 26(4):389-91. PubMed ID: 25424048
[TBL] [Abstract][Full Text] [Related]
55. On topical timolol gel-forming solution for infantile hemangiomas.
Berk DR; Lehman PA; Franz TJ; Blunt JR; Bayliss SJ
Pediatr Dermatol; 2013; 30(1):160-1. PubMed ID: 23316722
[No Abstract] [Full Text] [Related]
56. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.
Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X
J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976
[TBL] [Abstract][Full Text] [Related]
57. Application of Topical Timolol After CO2 Laser Resurfacing Expedites Healing.
Joo JS; Isseroff RR
Dermatol Surg; 2021 Mar; 47(3):429-431. PubMed ID: 31876577
[No Abstract] [Full Text] [Related]
58. Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient.
Martínez-de-Espronceda I; Bernabeu-Wittel J; Azcona M; Monserrat MT
Dermatol Ther; 2020 Jan; 33(1):e13164. PubMed ID: 31705590
[TBL] [Abstract][Full Text] [Related]
59. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
60. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution.
Guo S; Ni N
Arch Ophthalmol; 2010 Feb; 128(2):255-6. PubMed ID: 20142555
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
